This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Active Comparator Study.
Journal of diabetes, 17(4), e70077
Citation
Liu, Li; Cheng, Zhifeng; Wang, Lianwei; Zhang, Lili; Li, Shunbin; Li, Shu; Pang, Shuguang; Li, Qifu; Bian, Fang; Gu, Junling; Shen, Jie; Fu, Liujun; Sun, Baiping; Zhao, Yanyan; Dou, Changlin; Zeng, Zhaoyang; Guo, Lixin. (2025). Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Active Comparator Study.. Journal of diabetes, 17(4), e70077. https://doi.org/10.1111/1753-0407.70077